Digital Smaller, smarter devices for global trial diversity Consumer device giants are surging into the healthcare arena to make devices cheaper, more compact, and easier for patients to use.
News Novartis abandons Fabhalta trial in lupus nephritis A failed phase 2 study has undermined Novartis' hopes of extending the approved indications for Fabhalta to include lupus nephritis.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.